Anticonvulsant drugs, oxidative stress and nitric oxide

Proceedings of the Western Pharmacology Society

Volumn 54, Issue , 2011, Pages 40-47

  Vega Rasgado, L A ^a   Ceballos Reyes, G M ^a   Vega Diaz, M F ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMINOOXYACETIC ACID; DIAZEPAM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GABAPENTIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VALPROIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFECT; GABAERGIC TRANSMISSION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SEIZURE;

EID: 84863606428     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Halliwell B, G.J., (1999), Free radicals in biology and medicine. pp. 246-350. Oxford Univ. Press, NY.
2. Coyle, J.T. and Puttfarcken, P., (1993), Science 262, 689-695.
3. Engelborghs, S., D'Hooge, R. and De Deyn, P.P., (2000), Acta Neurol Belg 100, 201-213.
4. White, H.S., (1999), Epilepsia 40 Suppl 5, S2-10.
5. Holtkamp, M. and Meierkord, H., (2007), Cell Mol Life Sci 64, 2023-2041.
6. White, H.S., (1997), Epilepsia 38 Suppl 1, S9-17.
7. Garthwaite, J., (1991), Trends Neurosci 14, 60-67.
8. Moncada, S., Palmer, R.M. and Higgs, E.A., (1991), Pharmacol Rev 43, 109-142.
9. Prast, H. and Philippu, A., (2001), Prog Neurobiol 64, 51-68.
10. Przegalinski, E., Baran, L. and Siwanowicz, J., (1996), Neurosci Lett 217, 145-148.
11. De Sarro, G.B., Donato Di Paola, E., De Sarro, A. and Vidal, M.J., (1991), Fundam Clin Pharmacol 5, 503-511.
12. Osonoe, K., Mori, N., Suzuki, K. and Osonoe, M., (1994), Brain Res 663, 338-340.
13. Van Leeuwen, R., De Vries, R. and Dzoljic, M.R., (1995), Eur J Pharmacol 287, 211-213.
14. Nidhi, G., Balakrishnan, S. and Pandhi, P., (1999), Methods Find Exp Clin Pharmacol 21, 609-612.
15. Buisson, A., Lakhmeche, N., Verrecchia, C., Plotkine, M. and Boulu, R.G., (1993), Neuroreport 4, 444-446.
16. Starr, M.S. and Starr, B.S., (1993), Pharmacol Biochem Behav 45, 321-325.
17. Mulsch, A., Busse, R., Mordvintcev, P.I., Vanin, A.F., Nielsen, E.O., Scheel-Kruger, J. and Olesen, S.P., (1994), Neuroreport 5, 2325-2328.
18. Theard, M.A., Baughman, V.L., Wang, Q., Pelligrino, D.A. and Albrecht, R.F., (1995), Neuroreport 6, 921-924.
19. Smith, S.E., Man, C.M., Yip, P.K., Tang, E., Chapman, A.G. and Meldrum, B.S., (1996), Br J Pharmacol 119, 165-173.
20. Tsuda, M., Suzuki, T. and Misawa, M., (1997), Life Sci 60, PL339-343.
21. Yasuda, H., Fujii, M., Fujisawa, H., Ito, H. and Suzuki, M., (2001), Epilepsia 42, 13-20.
22. Del-Bel, E.A., Oliveira, P.R., Oliveira, J.A., Mishra, P.K., Jobe, P.C. and Garcia-Cairasco, N., (1997), Braz J Med Biol Res 30, 971-979.
23. Penix, L.P., Davis, W. and Subramaniam, S., (1994), Epilepsy Res 18, 177-84.
24. Tutka, P., et al., NG-nitro-L-arginine sensitizes mice to 4-aminopyridine-induced seizures. Acta Physiol Hung, 1996. 84(4): p. 471-2. (Pubitemid 126476465)
25. Patel, M.N., (2002), Free Radic Res 36, 1139-1146.
26. Stewart, V.C. and Heales, S.J., (2003), Free Radic Biol Med 34, 287-303.
27. Kiss, J.P. and Vizi, E.S., (2001), Trends Neurosci 24, 211-215.
28. Demchenko, I.T. and Piantadosi, C.A., (2006), Undersea Hyperb Med 33, 169-174.
29. Gonzalez-Hernandez, T., Garcia-Marin, V., Perez-Delgado, M.M., Gonzalez-Gonzalez, M.L., Rancel-Torres, N. and Gonzalez-Feria, L., (2000), Epilepsia 41, 1259-1268.
30. Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A. and Colombo, R., (2003), Clin Chim Acta 329, 23-38.
31. Wu, G.Y. and Brosnan, J.T., (1992), Biochem J 281 (Pt 1), 45-48.
32. Verdon, C.P., Burton, B.A. and Prior, R.L., (1995), Anal Biochem 224, 502-508.
33. Rojas-Hernandez, S., Rodriguez-Monroy, M.A., Moreno-Fierros, L., Jarillo-Luna, A., Carrasco-Yepez, M., Miliar-Garcia, A. and Campos-Rodriguez, R., (2007), Parasitol Res 101, 269-274.
34. Perez-Severiano, F., Escalante, B., Vergara, P., Rios, C. and Segovia, J., (2002), Brain Res 951, 36-42.
35. Segovia, J. and Perez-Severiano, F., (2004), Methods Mol Biol 277, 321-334.
36. Bredt, D.S. and Snyder, S.H., (1989), Proc Natl Acad Sci U S A 86, 9030-9033.
37. Garthwaite, J., Garthwaite, G., Palmer, R.M. and Moncada, S., (1989), Eur J Pharmacol 172, 413-416.
38. Jayakumar, A.R., Sujatha, R., Paul, V., Asokan, C., Govindasamy, S. and Jayakumar, R., (1999), Brain Res 837, 229-235.
39. Talarek, S. and Fidecka, S., (2003), Pol J Pharmacol 55, 181-191.
40. Kuriyama, K. and Ohkuma, S., (1995), Jpn J Pharmacol 69, 1-8.
41. Lonart, G., Wang, J. and Johnson, K.M., (1992), Eur J Pharmacol 220, 271-272.
42. Segovia, G. and Mora, F., (1998), Brain Res Bull 45, 275-279.
43. Mao, J. and Chen, L.L., (2000), Anesth Analg 91, 680-687.
44. Gee, N.S., Brown, J.P., Dissanayake, V.U., Offord, J., Thurlow, R. and Woodruff, G.N., (1996), J Biol Chem 271, 5768-5776.
45. Marais, E., Klugbauer, N. and Hofmann, F., (2001), Mol Pharmacol 59, 1243-8.
46. Gu, Y. and Huang, L.Y., (2001), Pain 93, 85-92.
47. Knowles, R.G. and Moncada, S., (1994), Biochem J 298 (Pt 2), 249-258.
48. Bredt, D.S. and Snyder, S.H., (1994), Annu Rev Biochem 63, 175-195.